The
Gene Discovery
On 23rd April, 2006, after 15 years of painstaking
research, the FOP research team at the University of Pennsylvania, School of
Medicine and their international collaborators, pinpointed a single gene
mutation—one out of 6 billion human genome—which is the culprit of such
devastating bone growth in Fibrodysplasia Ossificans Progressiva (FOP).
Senior authors Eileen M.Shore, Ph.D. and Frederick S. Kaplan, MD, both from the Penn Department of
Orthopaedic surgery and their international consortium of colleagues report
their findings on April 23rd, 2006 in advance online edition of “Nature Genetics”.
As per Kaplan “This discovery of the
FOP gene is relevant to every condition that affects the formation of bone and
every condition that affects the formation of the skeleton”.
Eileen Shore, a research associate
professor of orthopaedic surgery at the University of Pennsylvania, has been
studying the disease since 1991~ "I always had been interested in
development on a cellular level" she says— "What changes a cell, or
what regulates a cell to follow certain cell fate decisions? We usually think
about development on an organism level, but it was more a question of what
determines the personality of the cell?".
In 2009, Shore and her team found some
of the key biochemical steps that lead soft tissue cells to turn to bone—the
results were published in the ''Journal of Clinical Investigation'' in
November’09.
No comments:
Post a Comment